Global Vaccine Market Insights and Forecast to 2028

Global Vaccine Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Adult
1.3.3 For Child
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Market Perspective (2017-2028)
2.2 Vaccine Growth Trends by Region
2.2.1 Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Vaccine Historic Market Size by Region (2017-2022)
2.2.3 Vaccine Forecasted Market Size by Region (2023-2028)
2.3 Vaccine Market Dynamics
2.3.1 Vaccine Industry Trends
2.3.2 Vaccine Market Drivers
2.3.3 Vaccine Market Challenges
2.3.4 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Players by Revenue
3.1.1 Global Top Vaccine Players by Revenue (2017-2022)
3.1.2 Global Vaccine Revenue Market Share by Players (2017-2022)
3.2 Global Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Revenue
3.4 Global Vaccine Market Concentration Ratio
3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2021
3.5 Vaccine Key Players Head office and Area Served
3.6 Key Players Vaccine Product Solution and Service
3.7 Date of Enter into Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Breakdown Data by Type
4.1 Global Vaccine Historic Market Size by Type (2017-2022)
4.2 Global Vaccine Forecasted Market Size by Type (2023-2028)
5 Vaccine Breakdown Data by Application
5.1 Global Vaccine Historic Market Size by Application (2017-2022)
5.2 Global Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vaccine Market Size (2017-2028)
6.2 North America Vaccine Market Size by Type
6.2.1 North America Vaccine Market Size by Type (2017-2022)
6.2.2 North America Vaccine Market Size by Type (2023-2028)
6.2.3 North America Vaccine Market Share by Type (2017-2028)
6.3 North America Vaccine Market Size by Application
6.3.1 North America Vaccine Market Size by Application (2017-2022)
6.3.2 North America Vaccine Market Size by Application (2023-2028)
6.3.3 North America Vaccine Market Share by Application (2017-2028)
6.4 North America Vaccine Market Size by Country
6.4.1 North America Vaccine Market Size by Country (2017-2022)
6.4.2 North America Vaccine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Vaccine Market Size (2017-2028)
7.2 Europe Vaccine Market Size by Type
7.2.1 Europe Vaccine Market Size by Type (2017-2022)
7.2.2 Europe Vaccine Market Size by Type (2023-2028)
7.2.3 Europe Vaccine Market Share by Type (2017-2028)
7.3 Europe Vaccine Market Size by Application
7.3.1 Europe Vaccine Market Size by Application (2017-2022)
7.3.2 Europe Vaccine Market Size by Application (2023-2028)
7.3.3 Europe Vaccine Market Share by Application (2017-2028)
7.4 Europe Vaccine Market Size by Country
7.4.1 Europe Vaccine Market Size by Country (2017-2022)
7.4.2 Europe Vaccine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size (2017-2028)
8.2 Asia-Pacific Vaccine Market Size by Type
8.2.1 Asia-Pacific Vaccine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Vaccine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Vaccine Market Share by Type (2017-2028)
8.3 Asia-Pacific Vaccine Market Size by Application
8.3.1 Asia-Pacific Vaccine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Vaccine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Vaccine Market Share by Application (2017-2028)
8.4 Asia-Pacific Vaccine Market Size by Region
8.4.1 Asia-Pacific Vaccine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Vaccine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaccine Market Size (2017-2028)
9.2 Latin America Vaccine Market Size by Type
9.2.1 Latin America Vaccine Market Size by Type (2017-2022)
9.2.2 Latin America Vaccine Market Size by Type (2023-2028)
9.2.3 Latin America Vaccine Market Share by Type (2017-2028)
9.3 Latin America Vaccine Market Size by Application
9.3.1 Latin America Vaccine Market Size by Application (2017-2022)
9.3.2 Latin America Vaccine Market Size by Application (2023-2028)
9.3.3 Latin America Vaccine Market Share by Application (2017-2028)
9.4 Latin America Vaccine Market Size by Country
9.4.1 Latin America Vaccine Market Size by Country (2017-2022)
9.4.2 Latin America Vaccine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size (2017-2028)
10.2 Middle East & Africa Vaccine Market Size by Type
10.2.1 Middle East & Africa Vaccine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Vaccine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Vaccine Market Share by Type (2017-2028)
10.3 Middle East & Africa Vaccine Market Size by Application
10.3.1 Middle East & Africa Vaccine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Vaccine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Vaccine Market Share by Application (2017-2028)
10.4 Middle East & Africa Vaccine Market Size by Country
10.4.1 Middle East & Africa Vaccine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Vaccine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Vaccine Introduction
11.1.4 AstraZeneca Revenue in Vaccine Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Vaccine Introduction
11.2.4 BioNTech Revenue in Vaccine Business (2017-2022)
11.2.5 BioNTech Recent Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Details
11.3.2 Boehringer-Ingelheim Business Overview
11.3.3 Boehringer-Ingelheim Vaccine Introduction
11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2017-2022)
11.3.5 Boehringer-Ingelheim Recent Developments
11.4 CCBIO
11.4.1 CCBIO Company Details
11.4.2 CCBIO Business Overview
11.4.3 CCBIO Vaccine Introduction
11.4.4 CCBIO Revenue in Vaccine Business (2017-2022)
11.4.5 CCBIO Recent Developments
11.5 CSL
11.5.1 CSL Company Details
11.5.2 CSL Business Overview
11.5.3 CSL Vaccine Introduction
11.5.4 CSL Revenue in Vaccine Business (2017-2022)
11.5.5 CSL Recent Developments
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac Vaccine Introduction
11.6.4 CureVac Revenue in Vaccine Business (2017-2022)
11.6.5 CureVac Recent Developments
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Elanco Business Overview
11.7.3 Elanco Vaccine Introduction
11.7.4 Elanco Revenue in Vaccine Business (2017-2022)
11.7.5 Elanco Recent Developments
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Vaccine Introduction
11.8.4 GSK Revenue in Vaccine Business (2017-2022)
11.8.5 GSK Recent Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Details
11.9.2 Hulan Bio Business Overview
11.9.3 Hulan Bio Vaccine Introduction
11.9.4 Hulan Bio Revenue in Vaccine Business (2017-2022)
11.9.5 Hulan Bio Recent Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Details
11.10.2 Indian Immunologicals Business Overview
11.10.3 Indian Immunologicals Vaccine Introduction
11.10.4 Indian Immunologicals Revenue in Vaccine Business (2017-2022)
11.10.5 Indian Immunologicals Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Vaccine Introduction
11.11.4 Merck Revenue in Vaccine Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Details
11.12.2 Minhai Biotechnology Business Overview
11.12.3 Minhai Biotechnology Vaccine Introduction
11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2017-2022)
11.12.5 Minhai Biotechnology Recent Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Details
11.13.2 Mitsubishi Tanabe Pharma Business Overview
11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction
11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2017-2022)
11.13.5 Mitsubishi Tanabe Pharma Recent Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Details
11.14.2 Moderna Therapeutics Business Overview
11.14.3 Moderna Therapeutics Vaccine Introduction
11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2017-2022)
11.14.5 Moderna Therapeutics Recent Developments
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Vaccine Introduction
11.15.4 Mylan Revenue in Vaccine Business (2017-2022)
11.15.5 Mylan Recent Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Details
11.16.2 Plumbline Life Sciences Business Overview
11.16.3 Plumbline Life Sciences Vaccine Introduction
11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2017-2022)
11.16.5 Plumbline Life Sciences Recent Developments
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Vaccine Introduction
11.17.4 Sanofi Revenue in Vaccine Business (2017-2022)
11.17.5 Sanofi Recent Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Details
11.18.2 Translate Bio Business Overview
11.18.3 Translate Bio Vaccine Introduction
11.18.4 Translate Bio Revenue in Vaccine Business (2017-2022)
11.18.5 Translate Bio Recent Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Details
11.19.2 Walvax Biotechnology Business Overview
11.19.3 Walvax Biotechnology Vaccine Introduction
11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2017-2022)
11.19.5 Walvax Biotechnology Recent Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Details
11.20.2 Wuhan Institute of Biological Products Business Overview
11.20.3 Wuhan Institute of Biological Products Vaccine Introduction
11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2017-2022)
11.20.5 Wuhan Institute of Biological Products Recent Developments
11.21 Zoties
11.21.1 Zoties Company Details
11.21.2 Zoties Business Overview
11.21.3 Zoties Vaccine Introduction
11.21.4 Zoties Revenue in Vaccine Business (2017-2022)
11.21.5 Zoties Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Varicella Vaccine
Table 3. Key Players of Influenza Vaccine
Table 4. Key Players of Polio Vaccine
Table 5. Key Players of Hepatitis A Vaccine
Table 6. Key Players of Rabies Vaccine
Table 7. Key Players of BCG Vaccine
Table 8. Key Players of Hepatitis B
Table 9. Key Players of Pertussis, Diphtheria, Tetanus
Table 10. Key Players of Pneumococcal
Table 11. Key Players of Others
Table 12. Global Vaccine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 13. Global Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Vaccine Market Share by Region (2017-2022)
Table 16. Global Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Vaccine Market Share by Region (2023-2028)
Table 18. Vaccine Market Trends
Table 19. Vaccine Market Drivers
Table 20. Vaccine Market Challenges
Table 21. Vaccine Market Restraints
Table 22. Global Vaccine Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Vaccine Revenue Share by Players (2017-2022)
Table 24. Global Top Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2021)
Table 25. Ranking of Global Top Vaccine Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Vaccine Product Solution and Service
Table 29. Date of Enter into Vaccine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Vaccine Revenue Market Share by Type (2017-2022)
Table 33. Global Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Vaccine Revenue Market Share by Type (2023-2028)
Table 35. Global Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Vaccine Revenue Share by Application (2017-2022)
Table 37. Global Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Vaccine Revenue Share by Application (2023-2028)
Table 39. North America Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 40. North America Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 41. North America Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 42. North America Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 43. North America Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 44. North America Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 45. Europe Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 46. Europe Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 47. Europe Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 48. Europe Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 49. Europe Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 50. Europe Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 51. Asia Pacific Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 52. Asia Pacific Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 53. Asia Pacific Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 54. Asia Pacific Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 55. Asia Pacific Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 56. Asia Pacific Vaccine Market Size by Region (2023-2028) & (US$ Million)
Table 57. Latin America Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 58. Latin America Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 59. Latin America Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 60. Latin America Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 61. Latin America Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 62. Latin America Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 67. Middle East and Africa Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 68. Middle East and Africa Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Vaccine Product
Table 72. AstraZeneca Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. BioNTech Company Details
Table 75. BioNTech Business Overview
Table 76. BioNTech Vaccine Product
Table 77. BioNTech Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 78. BioNTech Recent Developments
Table 79. Boehringer-Ingelheim Company Details
Table 80. Boehringer-Ingelheim Business Overview
Table 81. Boehringer-Ingelheim Vaccine Product
Table 82. Boehringer-Ingelheim Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 83. Boehringer-Ingelheim Recent Developments
Table 84. CCBIO Company Details
Table 85. CCBIO Business Overview
Table 86. CCBIO Vaccine Product
Table 87. CCBIO Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 88. CCBIO Recent Developments
Table 89. CSL Company Details
Table 90. CSL Business Overview
Table 91. CSL Vaccine Product
Table 92. CSL Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 93. CSL Recent Developments
Table 94. CureVac Company Details
Table 95. CureVac Business Overview
Table 96. CureVac Vaccine Product
Table 97. CureVac Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 98. CureVac Recent Developments
Table 99. Elanco Company Details
Table 100. Elanco Business Overview
Table 101. Elanco Vaccine Product
Table 102. Elanco Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 103. Elanco Recent Developments
Table 104. GSK Company Details
Table 105. GSK Business Overview
Table 106. GSK Vaccine Product
Table 107. GSK Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 108. GSK Recent Developments
Table 109. Hulan Bio Company Details
Table 110. Hulan Bio Business Overview
Table 111. Hulan Bio Vaccine Product
Table 112. Hulan Bio Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 113. Hulan Bio Recent Developments
Table 114. Indian Immunologicals Company Details
Table 115. Indian Immunologicals Business Overview
Table 116. Indian Immunologicals Vaccine Product
Table 117. Indian Immunologicals Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 118. Indian Immunologicals Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Vaccine Product
Table 122. Merck Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. Minhai Biotechnology Company Details
Table 125. Minhai Biotechnology Business Overview
Table 126. Minhai Biotechnology Vaccine Product
Table 127. Minhai Biotechnology Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 128. Minhai Biotechnology Recent Developments
Table 129. Mitsubishi Tanabe Pharma Company Details
Table 130. Mitsubishi Tanabe Pharma Business Overview
Table 131. Mitsubishi Tanabe Pharma Vaccine Product
Table 132. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 133. Mitsubishi Tanabe Pharma Recent Developments
Table 134. Moderna Therapeutics Company Details
Table 135. Moderna Therapeutics Business Overview
Table 136. Moderna Therapeutics Vaccine Product
Table 137. Moderna Therapeutics Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 138. Moderna Therapeutics Recent Developments
Table 139. Mylan Company Details
Table 140. Mylan Business Overview
Table 141. Mylan Vaccine Product
Table 142. Mylan Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 143. Mylan Recent Developments
Table 144. Plumbline Life Sciences Company Details
Table 145. Plumbline Life Sciences Business Overview
Table 146. Plumbline Life Sciences Vaccine Product
Table 147. Plumbline Life Sciences Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 148. Plumbline Life Sciences Recent Developments
Table 149. Sanofi Company Details
Table 150. Sanofi Business Overview
Table 151. Sanofi Vaccine Product
Table 152. Sanofi Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 153. Sanofi Recent Developments
Table 154. Translate Bio Company Details
Table 155. Translate Bio Business Overview
Table 156. Translate Bio Vaccine Product
Table 157. Translate Bio Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 158. Translate Bio Recent Developments
Table 159. Walvax Biotechnology Company Details
Table 160. Walvax Biotechnology Business Overview
Table 161. Walvax Biotechnology Vaccine Product
Table 162. Walvax Biotechnology Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 163. Walvax Biotechnology Recent Developments
Table 164. Wuhan Institute of Biological Products Company Details
Table 165. Wuhan Institute of Biological Products Business Overview
Table 166. Wuhan Institute of Biological Products Vaccine Product
Table 167. Wuhan Institute of Biological Products Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 168. Wuhan Institute of Biological Products Recent Developments
Table 169. Zoties Company Details
Table 170. Zoties Business Overview
Table 171. Zoties Vaccine Product
Table 172. Zoties Revenue in Vaccine Business (2017-2022) & (US$ Million)
Table 173. Zoties Recent Developments
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccine Market Share by Type: 2021 VS 2028
Figure 2. Varicella Vaccine Features
Figure 3. Influenza Vaccine Features
Figure 4. Polio Vaccine Features
Figure 5. Hepatitis A Vaccine Features
Figure 6. Rabies Vaccine Features
Figure 7. BCG Vaccine Features
Figure 8. Hepatitis B Features
Figure 9. Pertussis, Diphtheria, Tetanus Features
Figure 10. Pneumococcal Features
Figure 11. Others Features
Figure 12. Global Vaccine Market Share by Application: 2021 VS 2028
Figure 13. For Adult Case Studies
Figure 14. For Child Case Studies
Figure 15. Vaccine Report Years Considered
Figure 16. Global Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Vaccine Market Share by Region: 2021 VS 2028
Figure 19. Global Vaccine Market Share by Players in 2021
Figure 20. Global Top Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2021
Figure 22. North America Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Vaccine Market Size Market Share by Type (2017-2028)
Figure 24. North America Vaccine Market Size Market Share by Application (2017-2028)
Figure 25. North America Vaccine Market Size Share by Country (2017-2028)
Figure 26. United States Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Vaccine Market Size Market Share by Type (2017-2028)
Figure 30. Europe Vaccine Market Size Market Share by Application (2017-2028)
Figure 31. Europe Vaccine Market Size Share by Country (2017-2028)
Figure 32. Germany Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Vaccine Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Vaccine Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Vaccine Market Size Share by Region (2017-2028)
Figure 42. China Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Latin America Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Vaccine Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Vaccine Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Vaccine Market Size Share by Country (2017-2028)
Figure 52. Mexico Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Vaccine Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Vaccine Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Vaccine Market Size Share by Country (2017-2028)
Figure 58. Turkey Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. AstraZeneca Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 62. BioNTech Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 63. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 64. CCBIO Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 65. CSL Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 66. CureVac Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 67. Elanco Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 68. GSK Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 69. Hulan Bio Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 70. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 71. Merck Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 72. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 73. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 74. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 75. Mylan Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 76. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 77. Sanofi Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 78. Translate Bio Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 79. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 80. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 81. Zoties Revenue Growth Rate in Vaccine Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs